AACR Annual Meeting 2023
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Join our experts at our poster sessions during AACR to learn more about
Session Information
Session 1
Session Category: Clinical Research Excluding Trials
Session Title: Cancer Outcomes 2
Date: Tuesday, April 18th, 2023
Time: 9:00 a.m. – 12:30 p.m.
Location: Poster Section 38
Poster Board Number: 13
Published Abstract Number: 4370
Abstract title: How Much Time Is Needed To Complete Quality of Life Assessments in Oncology Trials? – Metadata Analysis
Digitalization in clinical trials introduced electronic data collection. Participants in diverse environments can use electronic devices to report their experiences with the drug by completing patient reported outcome assessments (ePROs). Quality of life (QOL) reports describe how a patient feels or functions during a treatment with a new drug. For oncology trials, QOL data is needed to prove the treatment effect and support a labeling claim.
Authors: Jowita Marszewska and Lindsay Hughes
Presenter
Jowita Marszewska, Ph.D.
Scientific Advisor at Clario
Jowita Marszewska, Ph.D. is a Scientific Advisor at Clario, a global data and technology company that helps minimize risk in clinical trials. Dr. Marszewska has experience with electronic data capture and data management in clinical research. She advises on eCOA best practices, diary and instrument design and training for participants, caregivers and raters. Dr. Marszewska earned her M.Sc. and Ph.D. degrees in the field of chemistry. She has authored or co-authored 10 publications and has been an advocate for STEM education throughout her career.
Session 2
Session Category: Clinical Research Excluding Trials
Session Title: Clinical Informatics and Data Science / Retrospective Clinical Analyses 1
Date: Tuesday, April 18th, 2023
Time: 9:00 a.m. – 12:30 p.m.
Location: Poster Section 39
Poster Board Number: 7
Published Abstract Number: 4397
Abstract title: Chemotherapy-induced peripheral neuropathy and falls in cancer survivors relate to digital balance and gait impairments
Standing postural sway and gait tests with body-worn inertial sensors provide a multitude of objective, digital balance and gait measures that represent several different domains controlling mobility. However, it is not clear which domains of balance or gait best reflect the impact of treatment-induced peripheral neuropathy on mobility or differentiate fall risk in cancer survivors. The aim of this study was to determine which domains of balance and gait differed between cancer survivors who reported 1) symptoms of peripheral neuropathy versus asymptomatic survivors and 2) falls in the previous 6 months versus non-fallers.
Authors: Vrutangkumar V. Shah, Daniel Muzyka, Carolyn Guidarelli, Kristen Sowalsky, Kerri M. Winters-Stone, Fay B. Horak